Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000188:drug therapy*; D009268:Nalidixic Acid / Q000627:therapeutic use*; D010848:Picolinic Acids / Q000627:therapeutic use*; D011704:Pyelonephritis / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D011759:Pyrrolidines / Q000627:therapeutic use; D051381:Rats
D000900:Anti-Bacterial Agents; D010848:Picolinic Acids; D011743:Pyrimidines; D011759:Pyrrolidines; D009268:Nalidixic Acid